Canntab Therapeutics Pill is the Way Forward for Medical Cannabis Patients: CFO

We are at the tip of the iceberg and we expect a higher valuation, says Canntab Therapeutics Limited (CSE:PILL) CFO Richard Goldstein



In this interview at the Think: Investment Mashup, SmallCapPower spoke with Richard Goldstein, CFO of Canntab Therapeutics Limited (CSE:PILL), about the Company’s game changing proprietary hard tablet that improves the efficacy and absorption of medical cannabis. Canntab’s pill-based delivery mechanism allows for extended or sustained release of cannabis in the human body, lasting for a minimum of 12 to 18 hours. Mr. Goldstein also provides an update on the Company’s application to Health Canada to become a Licensed Producer (Non Grower). 

To read our full disclosure, please click on the button below: